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Abstract 
Background: Several pathogens have been debated to play a role in inflammatory bowel disease (IBD) including 
Crohn’s disease (CD). None of these pathogens have been investigated together in same clinical samples. We devel-
oped a multiplex PCR and multi-color fluorescent in situ hybridization (m-FISH) protocols for simultaneous detection 
of CD-associated pathogens including Mycobacterium avium subspecies paratuberculosis (MAP), Klebsiella pneumo-
niae, and adherent-invasive Escherichia coli strain LF82.
Methods: The multiplex PCR is based on 1-h  DNAzol® extraction protocol modified for rapid extraction of bacterial 
DNA from culture, blood, and intestinal biopsies. Oligonucleotide primers sequences unique to these pathogens were 
evaluated individually and in combinations using bioinformatics and experimental approaches. m-FISH was based on 
fluorescent-tagged oligonucleotides and confocal scanning laser microscopy (CSLM).
Results: Following several attempts, the concentration of the oligonucleotide primers and DNA templates and the 
PCR annealing temperatures were optimized. Multiplex PCR analyses revealed excellent amplification signal in trials 
where a single primer set and combinations of two and three primers sets were tested against a mixture of DNA from 
three different bacteria or a mixture of three bacterial cultures mixed in one tube before DNA extraction. Slides with 
individual and mixtures of bacterial cultures and intestinal tissue sections from IBD patients were tested by m-FISH 
and the CSLM images verified multiplex PCR results detected on 3% agarose gel.
Conclusion: We developed a 4-h multiplex PCR protocol, which was validated by m-FISH images, capable of detect-
ing up to four genes from major pathogens associated with CD. The new protocol should serve as an excellent tool to 
support efforts to study multi-pathogens involved in CD and other autoimmune disease.
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Background
Inflammatory bowel disease (IBD), which consists of 
Crohn’s disease (CD) and ulcerative colitis (UC), share 
a variety of different genetic factors, environmental 
triggers, and treatment plans [1–5]. Multiple recur-
ring reports from our laboratory and others provided 
evidence that environmental triggers including enteric 
pathogens may be associated with IBD. Specifically Myco-
bacterium avium subspecies paratuberculosis (MAP), 
adherent-invasive Escherichia coli (AIEC) strain LF82, 
and Klebsiella pneumoniae have been implicated as pos-
sible causative agents in CD [5–12].
MAP was first isolated as the causative agent for Johne’s 
disease, a CD-like enteritis in cattle [8, 9, 13, 14]. MAP 
is an intracellular acid-fast pathogen that infects mac-
rophages and dendritic cells and inhibits phagosome–lys-
osome fusion [15, 16]. Interestingly, MAP was detected 
in the blood, milk and intestinal biopsies from patients 
with CD and most recently from the blood of Rheuma-
toid Arthritis (RA) [5, 6, 8, 9]. On the other hand, AIEC 
is a gram-negative bacillus pathogen that has also been 
isolated from intestinal tissue from patients with CD [10, 
12, 17, 18]. AIEC strain LF82 has been studied intensely 
due to its ability to infiltrate intestinal tissue and increase 
pro-inflammatory cytokines level in CD patients [10, 12, 
17, 18]. Like MAP, AIEC strain LF82 resists phagosome–
lysosome fusion and acidification [10, 12, 17, 18]. Recent 
studies also showed that K. pneumoniae might be asso-
ciated with IBD pathogenesis [11, 19]. K. pneumoniae 
is a gram-negative, facultative anaerobic bacillus patho-
gen that causes pneumonia in immunocompromised 
patients [11, 19]. It colonizes the intestinal epithelial with 
an imbalance in gut flora leading to elevated humoral 
immune response [11, 19].
Although there are numerous studies investigating the 
role of these pathogens in CD pathogenesis, none of the 
studies examined the co-occurrence or co-roles of these 
pathogens in CD. Despite of the rationale why these 
pathogens were investigated individually for their role 
in CD, the outcome of each study may contributed to 
the controversy as to which microorganism really causes 
inflammation in CD, or which bacterium play a more 
important role in CD. For sure, it is challenging to use 
standard experimental techniques and less specialized 
skills to study diverse microorganisms together in indi-
vidual clinical samples. This study is designed to address 
these challenges in an attempt to develop the necessary 
protocols to evaluate the role of co-multiple pathogens 
in gastrointestinal tract inflammation. Consequently, we 
focused on development of a multiplex PCR based on 
rapid DNA extraction, and multi-color fluorescent in situ 
hybridization (m-FISH) on based specific oligonucleotide 
sequences.
Results
Use of  DNAzol® for rapid extraction of DNA from diverse 
pathogens
Several attempts were performed to modify the  DNAzol® 
technique to extract genomic DNA from diverse micro-
organisms and to evaluate the sensitivity and specificity 
of the new protocol, which we compared to the standard 
phenol/chloroform/isoamyl-alcohol DNA extraction pro-
tocol. A 1 h-DNAzol® protocol was developed. Following 
MAP-specific nPCR analysis,  DNAzol® extracts provided 
excellent PCR amplicons compared to the standard DNA 
extraction protocol. As shown in Fig.  1a, b, the oligo-
nucleotide primers used in the IS900 nPCR confirmed 
the specificity of the assay to MAP DNA. All non-MAP 
DNA extracts were negative for a 298  bp MAP ampli-
cons. Moreover, the positive PCR DNA bands were more 
intense with better resolution when  DNAzol® extracts 
were used. Sensitivity of the IS900 nPCR assay was evalu-
ated against serial dilutions of DNA templates from the 
two DNA extractions techniques. When comparing the 
sensitivity of the IS900 nPCR between the two DNA 
extraction techniques, the  DNAzol® extraction technique 
showed better sensitivity when examining serial dilutions 
Fig. 1 Specificity and sensitivity of the IS900 nPCR in DNA extracts 
from the modified  DNAzol® and the standard phenol/chloroform/
isoamyl-alcohol DNA extraction protocols. nPCR based on the IS900 
specific to MAP was performed on DNA template extracted by the 
standard phenol/chloroform/isoamyl-alcohol DNA extraction (I) 
and the modified  DNAzol® DNA extraction technique (II). A 298 bp 
fragment on 2% agarose gel is positive for MAP. a (1) Non-pathogenic 
E. coli strain K-12; (2) S. aureus; (3) L. monocytogenes; (4) K. pneumoniae; 
(5) M. smegmatis; (6) M. avium subspecies avium; (7) M. xenopi; (8) M. 
fortuitum subspecies fortuitum; (9) MAP Clinical Strain JF7. b (1) MAP 
Strain 1; (2) MAP Strain 3; (3) MAP Strain 8B; (4) MAP Para 18; (5) MAP 
UCF3; (6) MAP UCF5; (7) MAP UCF7; (8) MAP Linda; (9) MAP MS137. 
c Serial dilution of MAP UCF4 DNA concentrations were analyzed 
by nPCR. (1) 31.7 ng/μL; (2) 3.17 ng/μL; (3) 317 pg/μL; (4) 31.7 pg/μL; 
(5) 3.17 pg/μL; (6) 317 fg/μL; (7) 31.7 fg/μL; (8) 3.17 fg/μL; (9) 317 ag/
μL; (10) 31.7 ag/μL. +: MAP UCF4; N: No DNA; M: molecular weight 
marker
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of colony forming units (CFU) of MAP compared to the 
phenol/chloroform/isoamyl-alcohol DNA extraction 
technique. The minimum CFU detected by IS900 nPCR 
after  DNAzol® DNA extraction was ~ 2  CFU compared 
to ~ 5  CFU when the phenol/chloroform/isoamyl-alco-
hol DNA extract was used. The sensitivity of the IS900 
nPCR was not significantly different when DNA extracts 
were used from both protocols (Fig. 1c). Specifically, the 
minimum amount of MAP genome detected by the IS900 
nPCR from DNA extracts from the two protocols ranged 
between ~ 3.17 fg/L to 317 ag/μL.
Use of multiplex PCR on intestinal bacterial culture 
and tissue
We engineered an all in one multiplex PCR protocol that 
facilitates the detection of DNA from multiple bacte-
ria in a single intestinal tissue biopsy. First, the test was 
validated against DNA from a mixture of bacterial cul-
ture, which included non-pathogenic E. coli strain K-12, 
K. pneumoniae, and MAP. As shown in Fig. 2, the oligo-
nucleotides primers were specific to their correspond-
ing microorganism. There was no cross amplification 
between any of the primers used and DNA from any of 
the other microorganisms. Specifically, no cross ampli-
fication was observed when individual primers set were 
used against DNA from mixed cultures and when mix-
ture of the primers sets were used against individual bac-
terial DNA extracts. It is worth noting that we did not use 
DNA from AIEC strain LF82 due to laboratory biosafety 
level restrictions. In lieu of this, primers for AIEC strain 
LF82 were developed and tested against non-pathogenic 
E. coli strain K-12. The specificity of these primers were 
confirmed and validated against DNA and culture from 
non-pathogenic E. coli strain K-12. To add more sup-
port to the specificity of the MAP primers, Mycobacte-
rium avium complex (MAC) primers were used to allow 
detection of non-MAP mycobacterial DNA in clinical 
samples, if present.
Following optimization of DNA templates, oligonu-
cleotide primer and PCR temperature conditions, the 
modified  DNAzol® and the multiplex PCR protocols 
were used to evaluate intestinal biopsies from patients 
with UC (RS1) and CD (RS2). As shown in Table 1 and 
Fig.  3, DNA from both non-pathogenic E. coli strain 
K-12 (171 bp) and K. pneumoniae (493 bp) were detected 
in both RS1 and RS2 samples. MAP DNA (298 bp) was 
only detected in RS2 and not from RS1. AIEC strain LF82 
(357 bp) was not detected in all samples.
Microscopic staining and m‑FISH on intestinal bacterial 
culture and tissue
Gram and acid-fast stains were used to verify the pres-
ence and identity of the microorganisms used in this 
study. As shown in Fig. 4, a 1000× amplification images 
of bacteria stained with Gram stains (Fig. 4-1) and acid-
fast stains (Fig. 4-2) were illustrated. The m-FISH probes 
were specific to their corresponding microorganisms and 
there was no cross hybridization between probes used in 
this study (Fig. 4-3).
For the IBD patient biopsy samples (RS1 and RS2), indi-
vidual m-FISH probes were used along with DAPI (red 
fluorescence) to detect both the targeted bacteria and the 
tissue (Fig.  5). As with the multiplex PCR, m-FISH for 
Fig. 2 Validation of multiplex PCR using individual and combined 
oligonucleotide primer sets and DNA extracts from mixed bacterial 
culture. Multiplex PCR was performed on DNA extracts from mixed 
bacterial cultures. DNA template was extracted using the modified 
 DNAzol®. (1) Non-pathogenic E. coli strain K-12 18s primers were used 
(171 bp); (2) MAP UCF4 IS900 AV1/AV2 primers were used (298 bp); 
(3) K. pneumoniae 23s primers were used (493 bp); (4) Mycobacterium 
avium complex (MAC) IS1311 primers were used (534 bp); (5) a 
cocktail of the 4 primer sets mentioned above were used. M: DNA 
molecular weight marker
Table 1 Multiplex PCR and  m-FISH results for  intestinal 
tissue from IBD
AIEC: adherent-invasive Escherichia coli; MAP: Mycobacterium avium subspecies 
paratuberculosis; MAC: Mycobacterium avium complex; m-FISH: multi-color 
fluorescent in situ hybridization; RS1: ulcerative colitis patient; RS2: Crohn’s 
disease patient; ND: not done
Microorganism Intestinal tissue
RS1 RS2
Multiplex PCR m‑FISH Multiplex PCR m‑FISH
Non-pathogenic 
E. coli strain 
K-12
+ + + +
AIEC strain LF82 − − − −
MAP − − + +
K. pneumoniae + + + +
MAC − ND − ND
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non-pathogenic E. coli strain K-12 (AF647 fluorophore, 
blue fluorescence) and K. pneumoniae (AF546 fluoro-
phore, magenta fluorescence) showed positive signal-
ing in RS1 and RS2 tissue biopsies (Table 1, Fig. 5a-1, 2 
and d-1, 2), while only MAP (AF488 fluorophore, green 
fluorescence) was detected in the RS2 sample (Table  1, 
Fig. 5c-1, 2). The AIEC strain LF82 (AF568 fluorophore, 
yellow fluorescence) was not detected in either RS1 or 
RS2 tissue biopsies (Table 1, Fig. 5b-1, 2).
Use of multiple oligonucleotide probes via m‑FISH in IBD 
tissue
After optimization of the m-FISH protocol, we used two 
set of probes together to detect the presence or absence 
or co-presence of multiple microorganisms in same tis-
sue sections. We tested tissue sections from four CD sub-
jects (RS3, RS4, RS5, RS6) using our m-FISH. As shown 
in Fig.  6, images illustrate DAPI staining (blue fluores-
cence; a-1, b-1, c-1, d-1), non-pathogenic E. coli strain 
K-12 (AF657 fluorophore, red fluorescence, a-2, b-2, c-2, 
d-2), and MAP (AF488 fluorophore, green fluorescence, 
a-3, b-3, c-3, d-3). For RS3 and RS4, both non-pathogenic 
E. coli strain K-12 and MAP bacteria were successfully 
detected (Fig.  6a, b). RS5 (Fig.  6c-4) had only positive 
signaling for MAP, while RS6 (Fig. 6d-4) had only positive 
signaling for non-pathogenic E. coli strain K-12.
Discussion
Recent studies have strongly supported the role of 
microbial infection in IBD development [7–12]. It is 
still unclear which pathogen is found more readily in 
either UC or CD patients, where recent studies are more 
focused on detecting one pathogen at a time [8, 10, 11, 
18, 19]. In this study, the investigation of the presence of 
multiple pathogens including MAP, E. coli strains, and 
K. pneumoniae, was done to fully understand the role of 
possible co-infection or co-occurrence of multiple patho-
gens in individual IBD patients.
The development of a multiplex PCR protocol cou-
pled with an m-FISH detection protocol was successful, 
which together can detect multiple bacterial pathogens in 
a single sample. Along with this, a newly modified DNA 
extraction protocol was used in order to process the 
samples faster (~ 1  h) than previously used techniques 
(2–3 days) [5, 6, 8]. Overall, combining all three protocols 
has produced a faster, more efficient way into detecting 
multiple bacterial species in one test sample.
The effectiveness of the two DNA extractions tech-
niques that were used in this study was established, 
where the modified  DNAzol® technique showed simi-
lar specificity and sensitivity to the “traditional” phenol/
chloroform/isoamyl-alcohol DNA extraction technique 
(Fig.  1). The modified  DNAzol® DNA extraction tech-
nique however has the advantage over the “traditional” 
DNA extraction due to the simplistic and the less time 
consuming protocol, thus could potentially lead to more 
samples being processed at a time. Also, due to the cost-
effectiveness of the modified  DNAzol® DNA extraction 
protocol, which has a 1.5-fold lower cost than the “tra-
ditional” DNA extraction protocol, the modified protocol 
could be a better DNA extraction method to use in the 
clinical setting [20].
Fig. 3 Validation of multiplex PCR using individual and combined oligonucleotide primer sets and DNA extracts from IBD tissue. Multiplex PCR was 
performed on DNA extracts from intestinal tissue samples. DNA template was extracted using the modified  DNAzol®. RS1: ulcerative colitis (UC) 
patient; RS2: Crohn’s disease (CD) patient; (1) Non-pathogenic E. coli strain K-12 18s primers were used (171 bp); (2) MAP UCF4 IS900 AV1/AV2 primers 
were used (298 bp); (3) AIEC strain LF82 gipA primers were used (357 bp); (4) K. pneumoniae 23s primers were used (493 bp); (5) Mycobacterium 
avium complex (MAC) IS1311 primers were used (534 bp); (6) a cocktail of the 5 primer sets mentioned above were used. M: DNA molecular weight 
marker
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We developed a multiplex PCR that is specific to detect 
pathogens’ targets when DNA or bacteria were used 
purely or in a mixture (Figs.  2, 3). This technique was 
validated using DNA extracts from intestinal tissue from 
IBD subjects (Tables 1, 3). The labeling of oligonucleotide 
primers used in multiplex PCR with fluorophores in our 
m-FISH confirmed the identity of the microorganisms 
used in this study and the results obtained by multiplex 
PCR from intestinal tissue samples (Figs. 4, 5).
m-FISH illustrations validated the efficiency of the 
multiplex PCR in detecting multiple pathogens within 
hours using one protocol and limited reagents and steps. 
Fig. 4 Gram stain, acid-fast stain and m-FISH detection of bacterial cultures. Gram stain (1), acid-fast stain (2), and oligonucleotide m-FISH 
(3) images of bacterial cultures: a, b Non-pathogenic E. coli strain K-12; c MAP UCF4; and d K. pneumoniae. For -m-FISH detection: a3 m-FISH 
using non-pathogenic E. coli K-12 18s probe labeled with AF647 fluorophore; b3 m-FISH using AIEC strain LF82 gipA probe labeled with AF568 
fluorophore; c3 m-FISH using MAP UCF4 IS900 AV1 probe labeled with AF488 fluorophore; and d3 m-FISH using K. pneumoniae 23s probe labeled 
with AF546 fluorophore. All microscopic images were obtained at 1000 × magnification. White measurement bar found in D3 represents 100 μm. 
All m-FISH images were obtained using CSLM
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The significance of this technique will be tremendous 
for those investigating the role of multiple pathogens 
in tissue sections from patients with idiopathic or mul-
tifactorial diseases. Since CD is considered a syndrome 
with multifactorial etiology, the outcome of this study 
will provide new tools toward understanding which 
microorganism(s) is/are play significant role in disease 
pathogenies. As expected, both RS1 (UC) and RS2 (CD) 
were positive for non-pathogenic E. coli strain K-12 and 
K. pneumoniae (Fig.  6). However, detection of MAP in 
RS2 tissue (CD) and not in RS1 (UC) by multiplex PCR 
and validated with images by m-FISH support published 
reports of association of MAP with CD [5, 6, 8, 9, 13, 21]. 
Astonishing, both multiplex PCR and m-FISH did not 
detected the AIEC strain LF82 in the two IBD patients 
samples, where previous studies have shown that this 
bacterium has been associated with IBD pathogenesis [7, 
10, 12, 18]. This could be due to the small sample size in 
this study, but also could be due to the possibility that the 
gipA gene being amplified in the AIEC strain LF82 could 
be a low copy gene target [22, 23]. The virulent gene gipA 
was chosen as the target gene for amplification in AIEC 
strain LF82 is due to its association with AIEC infection 
in Peyer’s patches of CD patients [22, 23].
When comparing the intensities of the multiplex PCR 
DNA bands and the m-FISH signaling of non-pathogenic 
E. coli strain K-12 with the signaling of K. pneumoniae 
in both patient samples, it is evident that the dysregula-
tion of commensal E. coli could potentially play a role in 
a higher rate of K. pneumoniae infection in CD patients 
(Figs. 3, 5a, d). The data suggests that the more K. pneu-
moniae signaling is present in the CD patient (RS2) sam-
ple, the less non-pathogenic E. coli strain K-12 signaling 
is present. This could suggest and confirm that an oppor-
tunistic infection of K. pneumoniae can occur if there is 
a dysfunction of the microbiome in IBD patients due to 
the dysregulation of commensal bacteria, such as E. coli 
strain K-12 [11, 24–28]. With the increasing influx of K. 
pneumoniae in the CD patient more so in the UC patient, 
it could be a potential pathogen to investigate for CD 
pathogenesis studies.
The m-FISH assay on tissue from additional four other 
CD patients (RS3–RS6) showed that we able to detect 
and visualize multiple bacterial species in a single biopsy 
sample (Fig. 6). Further testing of more tissue from other 
diseases using the m-FISH probes and multiplex PCR for 
different microorganisms, such as other commensal bac-
teria species like Bacteroidetes fragilis and other oppor-
tunistic bacterial species like Pseudomonas aeruginosa, 
would be helpful to further validate these techniques to 
help elucidate idiopathic diseases with multiple etiology 
[29, 30].
Overall, this study was done as a pilot study in order to 
verify and examine these newly developed protocols, and 
as such, more IBD patient samples are required for future 
examination.
Methods
Bacterial cultures
A total of ten MAP strains, five other Mycobacterium 
species, and four non-Mycobacterium species were used 
Fig. 5 Use of m-FISH using individual probes to detect multiple 
pathogens in intestinal tissue. Oligonucleotide m-FISH analysis in 
tissue sections from patients with UC (RS1) and CD (RS2) was done 
targeting for: a Non-pathogenic E. coli strain K-12; b AIEC strain LF82; 
c MAP; and d K. pneumoniae. Images illustrating DAPI are in red. The 
individual m-FISH probes that were used were: a non-pathogenic 
E. coli strain K-12 18s probe labeled with AF647 fluorophore; b 
AIEC strain LF82 gipA probe labeled with AF568 fluorophore; c 
MAP UCF4 IS900 AV1 probe labeled with AF488 fluorophore; and 
d K. pneumoniae 23s probe labeled with AF546 fluorophore. White 
measurement bars found in D1 and D2 represents 20 μm. All m-FISH 
images were obtained using CSLM
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in this study (Table  2). Mycobacterium species includ-
ing MAP were cultured in BD Bactec™ MGIT™ Para-
TB medium (Becton, Dickinson and Company©) tubes 
supplemented with 800 μL of Bactec™ MGIT™ Para-TB 
Supplement (Becton, Dickinson and Company©) and 
incubated at 37  °C until optimal growth was achieved. 
E. coli, Staphylococcus aureus and K. pneumoniae were 
cultured in Luria broth (LB broth, Fisher  Scientific®) at 
37 °C. Listeria monocytogenes was cultured in brain heart 
infusion broth (BHI broth, Fisher  Scientific®) at 37 °C.
Intestinal tissue
Intestinal tissue from one UC (RS1) and from five CD 
(RS2, RS3, RS4, RS5, RS6) patients were used in this 
study. Tissue samples used in this originated from sub-
jects participated in earlier study and the unused tissue 
Fig. 6 Use of m-FISH using combined probes to detect multiple pathogens in intestinal tissue from CD. Oligonucleotide m-FISH images of 
intestinal tissue sections from four CD patients (a RS3, b RS4, c RS5, and d RS6). A combined probes mixture including (2) EC647 (non-pathogenic E. 
coli strain K-12 18s probe labeled with AF647 fluorophore) and (3) MAP488 (MAP UCF4 IS900 AV1 probe labeled with AF488 fluorophore) were used 
in all tissue sections. (1) DAPI staining and (4) merged images between DAPI and the corresponding probe. White measurement bar located in B3 
represents 20 μm. All m-FISH images were obtained using CSLM
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were stored at − 80  °C in Dr. Saleh A. Naser’s labora-
tory. These tissue were obtained following the Univer-
sity of Central Florida Institutional Review Board 
#IRB00001138 approval. Although limited information is 
available about these tissue samples, the tissue were use-
ful for this study since the intention is limited to valida-
tion of detection of selected microorganisms in IBD gut.
DNA extraction
Preparation of cell pellets/intestinal tissue lysate for DNA 
extraction
A volume of 1 mL of bacterial culture in 1.5 mL micro-
centrifuge tube was centrifuged at 13,000 RPMs for 
2.5  min at room temperature. Supernatant was dis-
carded and bacterial cell pellet was re-suspended in 
500  μL of tris–EDTA buffer (TE buffer). For intestinal 
tissue, approximately 1  g tissue block was placed in tis-
sue grinder (Precision™) with 1 mL of saline solution and 
was homogenized for 15 min. The tissue homogenate was 
then added to a lysing matrix B tubes (MP Biomedicals©) 
and was subjected to sonication using FastPrep FP120 
Cell Disrupter at 6.0 m/s for 30 s in a (Thermo Savant™). 
The lysate was then centrifuged at 13,000 RPMs for 
20  min. The supernatant was then removed from each 
tube and stored at − 20 °C until further use.
DNA extractions of both bacterial cell pellets and intes-
tinal tissue lysate were performed following our modified 
 DNAzol® (ThermoFisher  Scientific®) DNA extraction 
protocol and our traditional phenol/chloroform/isoamyl 
DNA extraction method as described previously [5, 6, 8].
Modified  DNAzol® DNA extraction protocol
Each tube containing bacterial culture pellet or intesti-
nal tissue lysate in 500 μL of TE was subjected to DNA 
extraction by a protocol that utilizes  DNAzol® as pre-
viously described [5, 6]. Briefly, a total of 1.0  mL of 
 DNAzol® was added to bacterial culture pellets or intes-
tinal tissue lysates suspended in 500 μL TE. After mixing, 
a 400 μL of 100% isopropanol was added to each tube and 
then incubated for 15 min at room temperature. Follow-
ing centrifugation at 8000 RPMs for 6 min, the superna-
tant was discarded and DNA pellets were then washed 
with 500 μL of  DNAzol® at 8000 RPMs for 5 min. DNA 
pellets were then washed again in 1.0 mL of 75% ethanol 
at 8000 RPMs for 5 min and then dried via a speedvac for 
5 min. Dried DNA pellets were then dissolved in 50 μL of 
TE buffer and stored at − 20 °C until further use.
Phenol/chloroform/isoamyl DNA extraction protocol
Each tube containing bacterial culture pellet or tissue 
lysate in 500 μL of TE was subjected to DNA extraction 
by a protocol that utilizes phenol/chloroform/isoamyl 
alcohol as previously described [8]. Briefly, tubes were 
incubated in a heat block for 30 min at 100 °C and then 
placed on ice for 15  min. Tubes were then centrifuged 
at 12,000 RPMs at 4  °C for 10  min. Supernatants were 
transferred into 2.0  mL Phase Lock Gel™ tubes (Fisher 
 Scientific®) and then mixed with 200 μL of phenol/chlo-
roform/isoamyl-alcohol (Fisher  Scientific®). Tubes were 
centrifuged at 12,000 RPMs at 4  °C for 5  min, where 
supernatants transferred into new 1.5  mL microcentri-
fuge tubes containing 100% chilled ethanol and stored at 
− 20 °C overnight. Next day, tubes are thawed and centri-
fuged at 12,000 RPMs at 4 °C for 10 min and the super-
natants discarded. DNA pellets were washed with 80% 
chilled ethanol, dried in a speedvac for 15  min and re-
suspended in 50 μL TE buffer for storage at − 20 °C until 
further use.
Validation of  DNAzol® extraction method by MAP IS900 
nPCR
MAP-specific nPCR based on IS900 derived oligonucleo-
tide primers (Table 3) was used to evaluate the efficiency 
of the modified  DNAzol® protocol compared to the phe-
nol/chloroform/isoamyl alcohol protocol. In the first 
round, the PCR reaction consisted of 25 μL master mix 
(2× solution containing Taq DNA polymerase, dNTPs, 
 MgCl2 and reaction buffers, Promega©), 5  μL betaine 
(Sigma-Aldrich©), 1 μL of P90 and 1 μL of P91 oligonu-
cleotide primers, 8  μL of Millipore  H2O, and 10  μL of 
DNA. The PCR cycling conditions were: 95 °C for 5 min; 
Table 2 Microorganisms used in this study
MAP: Mycobacterium avium subspecies paratuberculosis
Microorganism Source
MAP Strain 1 CD breast milk
MAP Strain 3 CD intestinal tissue
MAP Strain 8B CD blood
MAP Para 18 ATCC 19698
MAP UCF3 CD intestinal tissue
MAP UCF4 CD intestinal tissue
MAP UCF5 CD intestinal tissue
MAP UCF7 CD intestinal tissue
MAP Linda ATCC 43015
MAP MS137 CD intestinal tissue
Mycobacterium smegmatis ATCC 27199
Mycobacterium avium subspecies avium ATCC 25291
MAP clinical strain JF7 HIV blood
Mycobacterium xenopi ATCC 19971
Mycobacterium fortuitum subspecies fortuitum ATCC 23031
Non-pathogenic Escherichia coli Strain K-12 ATCC 8739
Staphylococcus aureus ATCC 25932
Klebsiella pneumoniae ATCC 13883
Listeria monocytogenes ATCC 19112
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35 cycles of 95 °C for 60 s, 58 °C for 90 s, and 72 °C for 
90  s; and a final extension of 72  °C for 10  min. For the 
second round of PCR, the same reagents were used from 
the first round with 5 μL of P90/P91 product and AV1/
AV2 oligonucleotide primers. The PCR cycling condi-
tions were: 95  °C for 5 min; 35 cycles of 95  °C for 30  s, 
60 °C for 30 s, and 72 °C for 60 s; and a final extension of 
72 °C for 10 min. Amplified DNA was then analyzed on a 
2% agarose gel, and a 298 bp band was considered posi-
tive for MAP. DNA from MAP clinical strain UCF4 was 
used a positive control. The negative control consisted of 
all reagents except DNA.
Development of multiplex PCR
All oligonucleotide primers were designed and then pur-
chased from Eurofins Genomics© (Table 3). Briefly, 10 μL 
of DNA containing 17 ng/μL of bacterial DNA or 50 ng/
μL tissue DNA were added into a 200 μL-microcentrifuge 
tube containing 25 μL of PCR Master Mix (2× solution 
containing Taq DNA polymerase, dNTPs, MgCl2 and 
reaction buffers, Promega©), 5  μL of betaine (Sigma-
Aldrich©), and 1  μL of each oligonucleotide primer 
(10 μM forward and 10 μM reverse primer for each bac-
terial species (MAP, MAC, non-pathogenic E. coli strain 
K-12, AIEC strain LF82, and K. pneumoniae). The PCR 
cycling conditions were: 95  °C for 5  min; 35 cycles of 
95  °C for 30 s, 60  °C for 30 s, and 72  °C for 60 s; and a 
final extension of 72  °C for 10 min. The products of the 
multiplex PCR were analyzed on a 3% agarose gel, where 
the following base pairs bands are considered positive 
for the bacterial species tested: 171  bp (non-pathogenic 
E. coli strain K-12), 298 bp (MAP), 357 bp (AIEC strain 
LF82), 493 bp (K. pneumoniae), and 543 bp (MAC). For 
the bacterial DNA positive controls, all tested bacterial 
species were first separated into individual tubes and 
underwent DNA extraction/multiplex PCR. Once suc-
cessful multiplex PCR was done on the bacterial DNA 
positive controls individually, all tested bacterial species 
Table 3 Nucleotide primers used in multiplex PCR and m-FISH probes
BLAST E-value: basic local alignment search tool expected value
Bacterial gene target nPCR primers Multiplex PCR primers m‑FISH probe
Mycobacterium avium subspecies 
paratuberculosis
(MAP)
IS900
P90: 5′-GTT CGG GGC 
CGT CGC TTA GG-3′
(BLAST E-value: 
2e−04)
P91: 5′-GAG GTC GAT 
CGC CCA CGT GA-3′
(BLAST E-value: 
2e−04)
AV1: 5′-ATG TGG 
TTG CTG TGT TGG 
ATGG-3′
(BLAST E-value: 
1e−05)
AV2: 5′-CCG CCG CAA 
TCA ACT CCA G-3′
(BLAST E-value: 
5e−04)
AV1: 5′-ATG TGG TTG CTG TGT TGG ATGG-3′
(BLAST E-value: 1e−05)
AV2: 5′-CCG CCG CAA TCA ACT CCA G-3′
(BLAST E-value: 5e−04)
AV1: 5′-AF488 ATG TGG TTG CTG TGT TGG 
ATGG-3′
(BLAST E-value: 1e−05)
Mycobacterium avium complex
(MAC)
IS1311
NA Forward: 5′-AAA CGA CCA AGG ATC ACT ACC 
GAG -3′
(BLAST E-value: 1e−06)
Reverse: 5′-GTC GAG GAA CAC ATA CGG GAAGT-
3′
(BLAST E-value: 4e−06)
NA
Non-pathogenic E. coli strain K-12
18s
NA Forward: 5′-CCG CAT AAC GTC GCA AGA CC-3′
(BLAST E-value: 6e−04)
Reverse: 5′-CGT AGG AGT CTG GAC CGT GTC-3′
(BLAST E-value: 2e−04)
5′-AF647 GGT CTT GCG ACG TTA TGC GG-3′
(BLAST E-value: 6e−04)
AIEC strain LF82
gipA
NA Forward: 5′-GCT GTG TGC GCT TCG TCT AC-3′
(BLAST E-value: 4e−08)
Reverse: 5′-GAT GGT AAT TCT CGA CTC CAG CGA 
-3′
(BLAST E-value: 2e−07)
5′-AF568 GTA GAC GAA GCG CAC ACA GC-3′
(BLAST E-value: 4e−08)
K. pneumoniae
23 s
NA Forward: 5′-TGG CAG TCA GAG GCG ATG AAG-3′
(BLAST E-value: 1e−04)
Reverse: 5′-CTT TCC CTC ACG GTA CTG GTTCA-3′
(BLAST E-value: 0.002)
5′-AF546 CTT CAT CGC CTC TGA CTG CCA-3′
(BLAST E-value: 0.001)
Page 10 of 12Sharp et al. Gut Pathog           (2018) 10:51 
were then added into one tube and then underwent DNA 
extraction/multiplex PCR. The negative control for the 
multiplex PCR step that was used had all of the necessary 
PCR reagents except for the DNA.
Development of multi‑color fluorescent in situ 
hybridization (m‑FISH) for imaging for gut bacteria
Preparation of bacterial slides for m‑FISH
A volume of 1 mL of bacterial culture in 1.5 mL micro-
centrifuge tube was centrifuged at 13,000 RPMs for 
2.5  min at room temperature. The supernatant was 
removed and the culture pellet was washed with 500 μL 
of TE and then centrifuged again at 13,000 RPMs for 
2.5  min at room temperature. After centrifugation, the 
supernatant was removed and the culture pellet was re-
suspended in 100 μL of TE. Of which, 20 μL suspension 
was placed on each slide, air dried and then heat fixed. 
Slides were then incubated in 4% paraformaldehyde 
(PFA, Fisher  Scientific®) overnight at 4 °C on a shaker at 
50 rpm.
Preparation of intestinal tissue slides for m‑FISH
Intestinal tissue sections were obtained using previously 
established protocols [31, 32]. In brief, PFA fixed tissue 
specimens (1 g each) were placed in perforated cassettes 
and immersed in ascending concentrations of ethanol 
(70%, 90%, and 100%) on a Leica processing system (TP 
1020) for dehydration followed by clearing in (Xylene 
50:Ethanol 50), and 100% Xylene solutions. Next, intes-
tinal tissue was embedded in melted paraffin (60 °C) and 
allowed to solidify to 4  °C. Solidified blocks were then 
cut using tissue microtome (HM 325 Microm; Medical 
Equipment Source) into consistent 5 μm thickness serial 
tissue sections and placed on Colorfrost Plus microscope 
slides (Fisher  Scientific®). Before histology evaluation, 
sections were put in 60  °C incubator for 30  min, and 
immersed into in xylene solution (Sigma-Aldrich©) for 
10  min to remove extra wax and three separate washes 
with 100% ethanol, 95% ethanol, and 70% ethanol for 10 
min each to rehydrate the tissue section. The tissue slides 
were air-dried after removal of paraffin, and incubated 
overnight at 4  °C with 4% PFA (Fisher  Scientific®) on a 
shaker.
Labeling of probes with fluorophores
An m-FISH protocol was developed in order to visually 
allow the detection of multiple microorganisms in a sin-
gle tissue section from intestinal biopsy sample. Oligonu-
cleotide primers used earlier in multiplex PCR (Table 3) 
were labeled with fluorophores (Eurofins Genomics©) as 
follows: non-pathogenic E. coli strain K-12 18s (AF647 
fluorophore, blue fluorescence), AIEC strain LF82 gipA 
(AF568 fluorophore, yellow fluorescence), MAP IS900 
(AV1 primer, AF488 fluorophore, green fluorescence), 
and K. pneumoniae 23s (AF546 fluorophore, magenta 
fluorescence) (Fig. 4). All m-FISH oligonucleotide probes 
were prepared by diluting probes to 1 μg/μL in TE buffer.
Gram and acid‑fast staining
For confirmation of bacterial presence and identity, we 
used standard staining including Gram and acid-fast 
staining [33, 34]. To prepare the bacteria culture slides, a 
volume of 1 mL of bacterial culture in 1.5 mL microcen-
trifuge tube was centrifuged at 13,000 RPMs for 2.5 min 
at room temperature. The supernatant was removed and 
the culture pellet was washed with 500  μL of TE and 
then centrifuged again at 13,000 RPMs for 2.5  min at 
room temperature. After centrifugation, the supernatant 
was removed and the culture pellet was re-suspended in 
100 μL of TE. Of which, 20 μL suspension was placed on 
a microscope slide, air dried and then heat fixed. Gram 
staining and acid-fast staining was done using the Fisher 
 Scientific® Gram staining kits and using their protocols.
Bacterial m‑FISH on bacterial slides and IBD patient’s biopsy 
slides
After fixation with 4% PFA, the slides were then 
washed three separate times in 1× phosphate buffer 
saline (PBS) for 10 min each on a shaker. Next, a solu-
tion comprising of 100  μL of 1% sodium dodecyl sul-
fate (SDS) with 2  μL of 20  mg/mL of Proteinase K 
(Thermo Scientific™) was added directly to the slides 
in hybridization chambers  (Corning®). The slides in the 
hybridization chambers were then incubated at 55  °C 
for 30  min. Inactivation of the Proteinase K was done 
by adding 200  μL of 0.2% glycine (Sigma-Aldrich©) to 
each slide and incubated for 3  min on a shaker. After 
inactivation, the slides were then washed three sepa-
rate times in 1× PBS for 5  min each on a shaker. The 
slides were washed again in the following solutions 
for 1 min each on a shaker: 50% ethanol, 80% ethanol, 
100% ethanol and then xylene. Next, the slides were 
washed once again with the following solutions for 
1  min each on a shaker: 100% ethanol, 80% ethanol, 
and 50% ethanol. After the ethanol/xylene washes, the 
slides are then incubated in 1× PBS for 60  min on a 
shaker. The slides were then incubated in a pre-hybrid-
ization solution consisting of 2× saline-sodium citrate 
(SSC, Sigma-Aldrich©), 20% dextran sulfate (Fisher 
 Scientific®), 50% formamide (Sigma-Aldrich©), 50 mM 
 NaH2PO4 (Sigma-Aldrich©), and 1  mM EDTA (Fisher 
 Scientific®) for 10 min at 50 °C. After incubation in the 
pre-hybridization solution, the slides are then placed 
in hybridization chambers and 20  μL of hybridization 
solution (pre-hybridization solution without the 20% 
dextran sulfate) was added directly to the samples. The 
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hybridization solution also included 3  μL of the 1  μg/
μL oligonucleotide fluorescent probe per slide for the 
bacterial species being detected. After the hybridiza-
tion solution was added to the slides in the hybridiza-
tion chambers, the slides were then incubated for 60 °C 
for 60 min and then 37  °C overnight. After incubation 
overnight, the slides were then washed with the fol-
lowing solutions for 15 min each on a shaker: 2× SSC, 
1× SSC, 0.3× SSC in 40  °C water bath, and 0.3× SSC 
in room temperature in the dark. The slides were then 
washed three separate times with  H2O for 15 min each 
on a shaker and then air-dried in the dark. A solution of 
DAPI/mounting medium  (Vectashield®) was added to 
the slides and were sealed with a slide cover. The slides 
were analyzed using confocal scanning laser micros-
copy (CSLM). The images created were analyzed on 
ImageJ (National Institute of Health).
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